Kevin D. Read

Automated design of ligands to polypharmacological profiles

Jérémy Besnard, G.F. Ruda, Vincent Setola et al. · Nature · 2012 · 832 citations · Full text

Engineering, Ligand-based Drug Design, Drug Design +8

A novel multiple-stage antimalarial agent that inhibits protein synthesis

Beatriz Baragaña, Irene Hallyburton, Neil R. Norcross et al. · Nature · 2015 · 452 citations · Full text

Antiparasitic Agent, Medicine, Malaria +4

N-myristoyltransferase inhibitors as new leads to treat sleeping sickness

Julie A. Frearson, Stephen Brand, Stuart P. McElroy et al. · Nature · 2010 · 304 citations · Full text

Sleep, Sleep Disorder, N-myristoyltransferase Inhibitors +5

Central Nervous System Drug Disposition: The Relationship between in Situ Brain Permeability and Brain Free Fraction

Scott Summerfield, Kevin D. Read, David J. Begley et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 279 citations

Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition

Julianty Frost, Carles Galdeano, Pedro Soares et al. · Nature Communications · 2016 · 233 citations · Full text